Has Angeline Beltsos received payments from drug or device companies?

Yes. Drug and device makers reported $95,684 in general payments to Angeline Beltsos across 223 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Angeline Beltsos did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Angeline Beltsos come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Angeline Beltsos

Reproductive Endocrinology · Chicago, ILNPI 1558404251

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (50.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Ferring Pharmaceuticals Inc. accounts for 65.6% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $46,257 and has fallen 99.1% since, to $427 in 2025. Among reproductive endocrinology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$95,684in general payments, 2019–2025

Across 223 payments — averaging $429.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Ferring Pharmaceuticals Inc.$63K
EMD Serono, Inc.$11K
Ferring Pharmaceuticals Ltd (uk)$10K
Merck$5K
Organon$5K
Coopersurgical, Inc.$1K
plus $407 from 11 others

What the payments were for

Consulting fees$26,86628%
Speaking & faculty fees$48,70151%
Travel & lodging$12,68013%
Food & beverage$7,4388%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Ferring Pharmaceuticals Inc.	90	$62,743
EMD Serono, Inc.	31	$11,268
Ferring Pharmaceuticals Ltd (uk)	6	$10,345
Merck	34	$4,991
Organon	27	$4,602
Coopersurgical, Inc.	15	$1,329
Kedrion Biopharma Inc.	1	$90
Avion Pharmaceuticals	6	$88
Galen US Inc	3	$49
Vertical Pharmaceuticals, LLC	2	$34
Covidien LP	1	$29
Braintree Laboratories, Inc.	2	$29
Exeltis, USA Inc.	1	$21
Galderma Laboratories, L.p.	1	$20
Cook Medical LLC	1	$18
Duchesnay USA Incorporated	1	$16
Olympus America Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$95,684 in reported general payments places this provider in the 95th percentile of 62 reproductive endocrinology providers in Illinois.

See all reproductive endocrinology providers in Illinois →

Other reproductive endocrinology in Chicago

Eve FeinbergChicago$117K
Roohi NajeemuddinChicago$88K
Barbara SoltesChicago$25K
Ilan Tur-KaspaChicago$21K
Serdar BulunChicago$10K
Erica LoudenChicago$7K
Jennifer Hirshfeld CytronChicago$2K
Ijeoma IkoChicago$2K
Seth LevrantChicago$2K
Allison KomorowskiChicago$2K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →